Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Protocol for outcome reporting and follow-up in the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest trial (TTM2)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Age-specific trends in incidence and survival of out-of-hospital cardiac arrest from presumed cardiac cause in Denmark 2002-2014

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Occurrence of shockable rhythm in out-of-hospital cardiac arrest over time: a report from the COSTA group

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Regional variation in out-of-hospital cardiac arrest: incidence and survival - a nationwide study of regions in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Survival after out-of-hospital cardiac arrest in Europe - Results of the EuReCa TWO study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Gisela Lilja
  • Niklas Nielsen
  • Susann Ullén
  • Erik Blennow Nordstrom
  • Josef Dankiewicz
  • Hans Friberg
  • Katarina Heimburg
  • Janus Christian Jakobsen
  • Helena Levin
  • Clifton Callaway
  • Alain Cariou
  • Glenn M Eastwood
  • Raimund Helbok
  • Jan Hovdenes
  • Hans Kirkegaard
  • Christoph Leithner
  • Matt P G Morgan
  • Per Nordberg
  • Mauro Oddo
  • Paolo Pelosi
  • Christian Rylander
  • Manoj Saxena
  • Fabio Silvio Taccone
  • Michal Siranec
  • Matthew P Wise
  • Paul J Young
  • Tobias Cronberg
Vis graf over relationer

AIMS: The TTM2-trial is a multi-centre randomised clinical trial where targeted temperature management (TTM) at 33 °C will be compared with normothermia and early treatment of fever (≥37.8°C) after Out-of-Hospital Cardiac Arrest (OHCA). This paper presents the design and rationale of the TTM2-trial follow-up, where information on secondary and exploratory outcomes will be collected. We also present the explorative outcome analyses which will focus on neurocognitive function and societal participation in OHCA-survivors.

METHODS: Blinded outcome-assessors will perform follow-up at 30-days after the OHCA with a telephone interview, including the modified Rankin Scale (mRS) and the Glasgow Outcome Scale Extended (GOSE). Face-to-face meetings will be performed at 6 and 24-months, and include reports on outcome from several sources of information: clinician-reported: mRS, GOSE; patient-reported: EuroQol-5 Dimensions-5 Level responses version (EQ-5D-5 L), Life satisfaction, Two Simple Questions; observer-reported: Informant Questionnaire on Cognitive Decline in the Elderly-Cardiac Arrest version (IQCODE-CA) and neurocognitive performance measures: Montreal Cognitive Assessment, (MoCA), Symbol Digit Modalities Test (SDMT). Exploratory analyses will be performed with an emphasis on brain injury in the survivors, where the two intervention groups will be compared for potential differences in neuro-cognitive function (MoCA, SDMT) and societal participation (GOSE). Strategies to increase inter-rater reliability and decrease missing data are described.

DISCUSSION: The TTM2-trial follow-up is a pragmatic yet detailed pre-planned and standardised assessment of patient's outcome designed to ensure data-quality, decrease missing data and provide optimal conditions to investigate clinically relevant effects of TTM, including OHCA-survivors' neurocognitive function and societal participation.

OriginalsprogEngelsk
TidsskriftResuscitation
Vol/bind150
Sider (fra-til)104-112
Antal sider9
ISSN0300-9572
DOI
StatusUdgivet - maj 2020

ID: 59623247